Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.
Ovarian Cancer Immunotherapy provides a broad overview of several aspects of basic sciences, and clinical and therapeutic aspects of immunotherapy for ovarian cancer, as well as state-of-the-art information on molecular genetics and biology. Chapters are written by a team of expert contributors from around the world and explore topics such as antibody therapeutics for ovarian carcinoma, emerging serum biomarkers, ovarian cancer immunity, adoptive cell immunotherapy, the biology of dendritic cells, the role of growth factors, and more.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Samir A. Farghaly, MD, PhD is a Professor Obstetrics and Gynecology at the Joan and Sanford I. Weill Medical College, Graduate School of Medical Sciences; Sandra and Edward Meyer Cancer Center; and New York-Presbyterian Hospital/Weill Cornell Medical Center in New York, NY. He received his MD and PhD in molecular biology from London University. Dr. Farghaly is the Founder and Editor-in Chief of Current Trends in Gynecologic Oncology, and The International Journal of Gynecological, Obstetrical, and Reproductive Medicine Research. He is a member of the editorial boards of 18 international medical journals on Gynecological Cancers, Gene Expression and Therapy, Women's Health, and Gynecology.
Inhaltsangabe
* Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic * Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis * Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer * Rouba Ali- Fehmi and Eman Abdulfatah * Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer? * Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian Cabillic * Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition * Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque * Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer * Samir A. Farghaly * Chapter 6: Antibody-based Therapy for Ovarian Cancer * Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan * Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer * Gregory Lee * Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer * Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi * Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer * Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe * Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer * Scott Moerdler and Xingxing Zang * Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy * Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica * Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer * Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams * Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions * Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel
* Chapter 1: Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic * Debra H. Josephs, Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis * Chapter 2: Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer * Rouba Ali- Fehmi and Eman Abdulfatah * Chapter 3: Ovarian Cancer Immunity: How Does Immune Suppression Grow Cancer? * Vincent Lavoué, Patrick Legembre, Jean Levêque, Fabrice Foucher, Sébastien Henno, and Florian Cabillic * Chapter 4: Ovarian Tumor Microenvironment and Innate Immune Recognition * Jocelyn Reader, Sarah Lynam, Amy Harper, Gautam Rao, Maya Matheny, and Dana M. Roque * Chapter 5: Adoptive Cell Immunotherapy for Epithelial Ovarian Cancer * Samir A. Farghaly * Chapter 6: Antibody-based Therapy for Ovarian Cancer * Yousef Alharbi, Manish S. Patankar, and Rebecca J. Whelan * Chapter 7: Epitope/Peptide-based Monoclonal Antibodies for Immunotherapy of Ovarian Cancer * Gregory Lee * Chapter 8: Dendritic Cell Vaccine Therapy for Ovarian Cancer * Caitlin Stashwick, Brian J. Czerniecki, Janos L. Tanyi * Chapter 9: Heat Shock Protein Vaccine Therapy for Ovarian Cancer * Hiroyuki Abe, Amane Sasada, Shigeki Tabata, and Minako Abe * Chapter 10: PD-1 /PDL-1 Inhibitors as Immunotherapy for Ovarian Cancer * Scott Moerdler and Xingxing Zang * Chapter 11: Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy * Anca Maria Cimpean, Andreea Adriana Jitariu, and Marius Raica * Chapter 12: Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer * Michelle N. Messmer, Colleen S. Netherby, and Scott I. Abrams * Chapter 13: Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions * Justin M. Drerup, Curtis A. Clark, and Tyler J. Curiel
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
